Pages: Global Benchmarking Survey
Regulatory regimes can make or break the industry’s ability to fulfil its function of providing medical solutions to prevent and combat animal disease in an effective, cost-efficient and sustainable manner.
The purpose of the HealthforAnimals Global Benchmarking Survey (GBS) is to examine the interactions between industry and regulatory systems for veterinary medicinal products, particularly the impact of regulations on the animal health industry’s ability to access markets, be innovative and be competitive. This includes:
- Ability to bring new products to the market
- Ability to retain and continue to commercialise existing products
- Overall impact on the general availability of veterinary medicinal products
- Identification of emerging issues in the regulatory environment that may have a bearing on these market indicators.
The survey is run every 5 years with the cooperation and involvement of the HealthforAnimals national or regional member associations. This also permits monitoring of trends and competitiveness, ability to do business and on medicines availability. The survey is also a useful tool to gain insight into the expectations of the industry over the next 2-3 years in response to current regulatory dynamics.
The outcome of this survey provides a wealth of information to support informed policy decisions in the continual search for best regulatory practice and opportunities for improvement.
Download the Benchmarking Survey Reports
Note: Reports from Mexico, Australia and USA will not be published due to insufficient data
3-Part Analysis Series
Read our series at OpenAccessGovernment.org where HealthforAnimals Technical Director, Rick Clayton, unpacks the 2020 GBS in more detail:
